Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs

DUBLIN and INDIANAPOLIS Jan. 9 2017 PRNewswire Allergan plc NYSE AGN and Assembly Biosciences Inc. NASDAQ ASMB today announced that Allergan has entered into a research development collaboration and license agreement for the worldwide rights to Assembly's...